Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CANADIAN PATENTED DRUG PRICE REDUCTIONS OF UP TO 1.1%

Executive Summary

CANADIAN PATENTED DRUG PRICE REDUCTIONS OF UP TO 1.1% effective in January "will be required in cases where companies are currently charging the maximum allowable prices," the Canadian Patented Medicine Prices Review Board reports in its July 1994 Bulletin. Prices for patented drags in Canada are indexed to inflation by the Consumer Price Index. "The most recent forecast of the Department of Finance is that the CPI will increase by 1.3% in 1995 over 1994," the Bulletin states. However, the 1995 forecast "is actually below" the forecast CPI for the current year.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS024881

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel